3-deoxyglucosone has been researched along with ascorbic acid in 1 studies
| Studies (3-deoxyglucosone) | Trials (3-deoxyglucosone) | Recent Studies (post-2010) (3-deoxyglucosone) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
|---|---|---|---|---|---|
| 186 | 8 | 77 | 45,261 | 2,497 | 11,176 |
| Protein | Taxonomy | 3-deoxyglucosone (IC50) | ascorbic acid (IC50) |
|---|---|---|---|
| Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
| Urease | Canavalia ensiformis (jack bean) | 8.59 | |
| Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baynes, JW; Bleich, M; Busch, AE; Deemer, EK; Dingermann, T; Huber, J; Münch, G; Schäfer, S; Schmid, K; Somoza, V; Wihler, C | 1 |
1 other study(ies) available for 3-deoxyglucosone and ascorbic acid
| Article | Year |
|---|---|
Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Ascorbic Acid; Blood Glucose; Chromatography, High Pressure Liquid; Creatine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Glycation End Products, Advanced; Heterocyclic Compounds, 3-Ring; Kidney; Lysine; Male; Oxidation-Reduction; Protease Inhibitors; Ramipril; Rats; Rats, Zucker; Spectrometry, Fluorescence | 2005 |